30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Nexgel Inc (NXGL)

Track

Over the last 90 days, Nexgel Inc. has seen a net insider selling of $14,268.39. The Chief Executive Officer, Adam R. Levy, has been the primary seller, with multiple transactions totaling over $41,000. There have been no reported insider purchases during this period. The stock has experienced a 33.5% decline in the past 90 days.
Stock chart
Ticker: NXGL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Levy Adam R.
Chief Executive Officer
1 sale — total 100,000 USD
Sale 11 Jun 2026
Value US$654,936.62 | Price 105.49 | Shares 27,930
Sale 8 Jun 2026
Value US$292,883.76 | Price 348.39 | Shares 84,462
Sale 4 Jun 2026
Value US$100,000.00 | Price 0.59 | Shares 1,000
Sale 1 Jun 2026
Value US$100,000.00 | Price 0.59 | Shares 1,000
Sale 29 May 2026
Value US$1,800.90 | Price 0.60 | Shares 3,000
Sale 28 May 2026
Value US$4,240.60 | Price 0.61 | Shares 7,000
Sale 27 May 2026
Value US$1,792.50 | Price 0.60 | Shares 3,000
Proposed sale 27 May 2026
Value US$27,065.00 | Price 0.54 | Shares 50,000
Sale 24 Dec 2025
Value US$6,286.40 | Price 1.57 | Shares 4,000
Sale 22 Dec 2025
Value US$9,660.60 | Price 1.61 | Shares 6,000
Proposed sale 22 Dec 2025
Value US$16,400.00 | Price 1.64 | Shares 10,000
Planned sale 6 Nov 2025
Value US$10,084.40 | Price 2.52 | Shares 4,000
Planned sale 3 Oct 2025
Value US$6,119.28 | Price 2.55 | Shares 2,400
Planned sale 3 Oct 2025
Value US$18,297.68 | Price 2.55 | Shares 7,175
Planned sale 2 Oct 2025
Value US$4,000.00 | Price 2.50 | Shares 1,600
Proposed sale 2 Oct 2025
Value US$40,000.00 | Price 2.50 | Shares 16,000
Planned sale 2 Oct 2025
Value US$2,062.50 | Price 2.50 | Shares 825
Planned sale 25 Sep 2025
Value US$18,148.76 | Price 2.36 | Shares 7,697
Proposed sale 25 Sep 2025
Value US$108,451.00 | Price 3.05 | Shares 35,515
Sale 28 Aug 2025
Value US$9,896.40 | Price 2.47 | Shares 4,000
Proposed sale 28 Aug 2025
Value US$9,800.00 | Price 2.45 | Shares 4,000
Planned sale 13 Jun 2025
Value US$7,704.30 | Price 2.57 | Shares 3,000
Sale 11 Jun 2025
Value US$4,780.00 | Price 2.39 | Shares 2,000
Sale 9 Jun 2025
Value US$4,659.00 | Price 2.33 | Shares 2,000
Sale 5 Jun 2025
Value US$2,323.10 | Price 2.32 | Shares 1,000
Sale 4 Jun 2025
Value US$2,290.10 | Price 2.29 | Shares 1,000
Sale 30 May 2025
Value US$2,220.00 | Price 2.22 | Shares 1,000
Sale 16 May 2025
Value US$2,575.00 | Price 2.58 | Shares 1,000
Proposed sale 16 May 2025
Value US$18,960.00 | Price 2.37 | Shares 8,000
Planned sale 12 May 2025
Value US$8,061.90 | Price 2.69 | Shares 3,000
Planned sale 10 Apr 2025
Value US$7,824.90 | Price 2.61 | Shares 3,000
Proposed sale 10 Apr 2025
Value US$23,400.00 | Price 2.60 | Shares 9,000
Planned sale 1 Apr 2025
Value US$12,038.40 | Price 3.01 | Shares 4,000
Planned sale 10 Mar 2025
Value US$8,621.10 | Price 2.87 | Shares 3,000
Planned sale 3 Mar 2025
Value US$12,638.80 | Price 3.16 | Shares 4,000
Planned sale 10 Feb 2025
Value US$9,798.30 | Price 3.27 | Shares 3,000
Planned sale 3 Feb 2025
Value US$14,557.60 | Price 3.64 | Shares 4,000
Planned sale 7 Jan 2025
Value US$10,096.50 | Price 3.37 | Shares 3,000
Planned sale 2 Jan 2025
Value US$15,827.60 | Price 3.96 | Shares 4,000
Proposed sale 2 Jan 2025
Value US$64,480.00 | Price 4.03 | Shares 16,000
Planned sale 20 Dec 2024
Value US$13,934.70 | Price 4.64 | Shares 3,000
Proposed sale 20 Dec 2024
Value US$55,620.00 | Price 4.64 | Shares 12,000
Buy 20 Nov 2024
Value US$4,999.50 | Price 2.75 | Shares 1,818
Buy 20 Nov 2024
Value US$9,999.00 | Price 2.75 | Shares 3,636
Buy 20 Nov 2024
Value US$24,997.50 | Price 2.75 | Shares 9,090
Buy 20 Nov 2024
Value US$9,999.00 | Price 2.75 | Shares 3,636
Buy 20 Nov 2024
Value US$9,999.00 | Price 2.75 | Shares 3,636
Buy 20 Nov 2024
Value US$48,125.00 | Price 2.75 | Shares 17,500
Buy 23 Aug 2024
Value US$25,000.00 | Price 2.50 | Shares 10,000
Buy 23 Aug 2024
Value US$25,000.00 | Price 2.50 | Shares 10,000
Buy 23 Aug 2024
Value US$25,000.00 | Price 2.50 | Shares 10,000
Buy 23 Aug 2024
Value US$25,000.00 | Price 2.50 | Shares 10,000
Buy 23 Aug 2024
Value US$25,000.00 | Price 2.50 | Shares 10,000
Buy 1 Mar 2024
Value US$100,001.34 | Price 2.11 | Shares 47,394
Buy 1 Mar 2024
Value US$50,000.67 | Price 2.11 | Shares 23,697
Buy 1 Mar 2024
Value US$24,999.28 | Price 2.11 | Shares 11,848
Buy 22 Dec 2023
Value US$8,535.34 | Price 2.20 | Shares 3,885
Buy 26 Sep 2023
Value US$4,900.00 | Price 1.96 | Shares 2,500
Buy 14 Sep 2023
Value US$1,135.00 | Price 2.27 | Shares 500
Buy 13 Sep 2023
Value US$13,499.40 | Price 2.25 | Shares 6,000
Buy 12 Sep 2023
Value US$9,115.20 | Price 2.28 | Shares 4,000
Buy 22 Aug 2023
Value US$1,881.60 | Price 1.92 | Shares 980
Buy 21 Aug 2023
Value US$3,900.00 | Price 1.95 | Shares 2,000
Buy 8 Jun 2023
Value US$7,984.15 | Price 2.24 | Shares 3,558
Buy 8 Jun 2023
Value US$11,400.00 | Price 2.28 | Shares 5,000
Buy 8 Jun 2023
Value US$2,220.00 | Price 2.22 | Shares 1,000
Buy 7 Jun 2023
Value US$13,450.00 | Price 2.69 | Shares 5,000
Buy 7 Jun 2023
Value US$5,000.00 | Price 2.50 | Shares 2,000
Buy 2 Jun 2023
Value US$4,800.00 | Price 2.40 | Shares 2,000
Buy 31 May 2023
Value US$2,250.00 | Price 2.25 | Shares 1,000
Buy 31 May 2023
Value US$4,840.00 | Price 2.42 | Shares 2,000
Buy 30 May 2023
Value US$9,996.00 | Price 2.38 | Shares 4,200
Buy 30 May 2023
Value US$12,650.00 | Price 2.53 | Shares 5,000
Buy 26 May 2023
Value US$11,688.50 | Price 2.34 | Shares 5,000
Buy 24 May 2023
Value US$4,020.00 | Price 2.01 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-11 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
27,930 +33.8%
105.49
US$654,937 		27,930 +33.8% 105.49 US$654,937
2026-06-09 2026-06-08 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
84,462 +20.6%
348.39
US$292,884 		84,462 +20.6% 348.39 US$292,884
2026-06-09 2026-06-04 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
50,020 +46.1%
103.21
US$1,745,954 		50,020 +46.1% 103.21 US$1,745,954
2026-06-03 2026-06-01 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,000 -0.6%
0.59
US$100,000 		1,000 -0.6% 0.59 US$100,000
2026-05-29 2026-05-29 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
3,000 -0.9%
0.60
US$1,801 		3,000 -0.9% 0.60 US$1,801
2026-05-29 2026-05-28 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
7,000 -2.0%
0.61
US$4,241 		7,000 -2.0% 0.61 US$4,241
2026-05-29 2026-05-27 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
3,000 -0.8%
0.60
US$1,792 		3,000 -0.8% 0.60 US$1,792
2026-05-27 2026-05-27 PrS Proposed sale
3.2
Levy Adam R.

Officer

Officer
50,000
0.54
US$27,065 		50,000 0.54 US$27,065
2025-12-29 2025-12-24 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.1%
1.57
US$6,286 		4,000 -1.1% 1.57 US$6,286
2025-12-29 2025-12-22 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
6,000 -1.6%
1.61
US$9,661 		6,000 -1.6% 1.61 US$9,661
2025-12-22 2025-12-22 PrS Proposed sale
3.2
Levy Adam R.

Officer

Officer
10,000
1.64
US$16,400 		10,000 1.64 US$16,400
2025-11-07 2025-11-06 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.1%
2.52
US$10,084 		4,000 -1.1% 2.52 US$10,084
2025-10-06 2025-10-03 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
2,400 -0.6%
2.55
US$6,119 		2,400 -0.6% 2.55 US$6,119
2025-10-06 2025-10-03 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
7,175 -6.0%
2.55
US$18,298 		7,175 -6.0% 2.55 US$18,298
2025-10-06 2025-10-02 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,600 -0.4%
2.50
US$4,000 		1,600 -0.4% 2.50 US$4,000
2025-10-06 2025-10-02 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
825 -0.7%
2.50
US$2,062 		825 -0.7% 2.50 US$2,062
2025-10-02 2025-10-02 PrS Proposed sale
3.2
Levy Adam R.

Officer; Director

Executive Director
16,000
2.50
US$40,000 		16,000 2.50 US$40,000
2025-09-29 2025-09-25 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
7,697 -6.0%
2.36
US$18,149 		7,697 -6.0% 2.36 US$18,149
2025-09-25 2025-09-25 PrS Proposed sale
3.6
Henry Scott Robert

Director

Non-Executive Director
35,515
3.05
US$108,451 		35,515 3.05 US$108,451
2025-08-29 2025-08-28 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.1%
2.47
US$9,896 		4,000 -1.1% 2.47 US$9,896
2025-08-28 2025-08-28 PrS Proposed sale
3.2
Levy Adam R.

Officer

Officer
4,000
2.45
US$9,800 		4,000 2.45 US$9,800
2025-06-16 2025-06-13 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.3%
2.57
US$7,704 		3,000 -2.3% 2.57 US$7,704
2025-06-11 2025-06-11 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
2,000 -0.5%
2.39
US$4,780 		2,000 -0.5% 2.39 US$4,780
2025-06-11 2025-06-09 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
2,000 -0.5%
2.33
US$4,659 		2,000 -0.5% 2.33 US$4,659
2025-06-06 2025-06-05 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,000 -0.3%
2.32
US$2,323 		1,000 -0.3% 2.32 US$2,323
2025-06-06 2025-06-04 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,000 -0.3%
2.29
US$2,290 		1,000 -0.3% 2.29 US$2,290
2025-06-02 2025-05-30 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,000 -0.3%
2.22
US$2,220 		1,000 -0.3% 2.22 US$2,220
2025-05-20 2025-05-16 S Sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
1,000 -0.3%
2.58
US$2,575 		1,000 -0.3% 2.58 US$2,575
2025-05-16 2025-05-16 PrS Proposed sale
3.2
Levy Adam R.

Officer

Officer
8,000
2.37
US$18,960 		8,000 2.37 US$18,960
2025-05-13 2025-05-12 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.2%
2.69
US$8,062 		3,000 -2.2% 2.69 US$8,062
2025-04-14 2025-04-10 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.2%
2.61
US$7,825 		3,000 -2.2% 2.61 US$7,825
2025-04-10 2025-04-10 PrS Proposed sale
3.6
Henry Scott Robert

Director

Non-Executive Director
9,000
2.60
US$23,400 		9,000 2.60 US$23,400
2025-04-02 2025-04-01 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.1%
3.01
US$12,038 		4,000 -1.1% 3.01 US$12,038
2025-03-11 2025-03-10 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.1%
2.87
US$8,621 		3,000 -2.1% 2.87 US$8,621
2025-03-05 2025-03-03 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.1%
3.16
US$12,639 		4,000 -1.1% 3.16 US$12,639
2025-02-12 2025-02-10 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.1%
3.27
US$9,798 		3,000 -2.1% 3.27 US$9,798
2025-02-05 2025-02-03 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.0%
3.64
US$14,558 		4,000 -1.0% 3.64 US$14,558
2025-01-08 2025-01-07 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.1%
3.37
US$10,096 		3,000 -2.1% 3.37 US$10,096
2025-01-06 2025-01-02 PlS Planned sale
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
4,000 -1.0%
3.96
US$15,828 		4,000 -1.0% 3.96 US$15,828
2025-01-02 2025-01-02 PrS Proposed sale
3.2
Levy Adam R.

Officer; Director

Executive Director
16,000
4.03
US$64,480 		16,000 4.03 US$64,480
2024-12-23 2024-12-20 PlS Planned sale
3.6
Henry Scott Robert
Non-Executive Director
3,000 -2.0%
4.64
US$13,935 		3,000 -2.0% 4.64 US$13,935
2024-12-20 2024-12-20 PrS Proposed sale
3.6
Henry Scott Robert

Director

Non-Executive Director
12,000
4.64
US$55,620 		12,000 4.64 US$55,620
2024-11-22 2024-11-20 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
1,818 +1.2%
2.75
US$5,000 		1,818 +1.2% 2.75 US$5,000
2024-11-22 2024-11-20 B Purchase
3.2
Stein John Nachum
Non-Executive Director
3,636 +0.8%
2.75
US$9,999 		3,636 +0.8% 2.75 US$9,999
2024-11-22 2024-11-20 B Purchase
3.4
glassman steven mark
Non-Executive Director
9,090 +6.3%
2.75
US$24,998 		9,090 +6.3% 2.75 US$24,998
2024-11-22 2024-11-20 B Purchase
3.1
ZELDIS JEROME B
Non-Executive Director
3,636 +3.5%
2.75
US$9,999 		3,636 +3.5% 2.75 US$9,999
2024-11-22 2024-11-20 B Purchase
3.2
Levy Adam R.

Chief Executive Officer

Executive Director
3,636 +1.1%
2.75
US$9,999 		3,636 +1.1% 2.75 US$9,999
2024-11-22 2024-11-20 B Purchase
3.4
Drapczuk Adam E III

Chief Financial Officer

Officer
17,500 +30.5%
2.75
US$48,125 		17,500 +30.5% 2.75 US$48,125
2024-08-28 2024-08-23 B Purchase
3.2
Stein John Nachum
Non-Executive Director
10,000 +2.2%
2.50
US$25,000 		10,000 +2.2% 2.50 US$25,000
2024-08-27 2024-08-23 B Purchase
3.1
ZELDIS JEROME B
Non-Executive Director
10,000 +10.7%
2.50
US$25,000 		10,000 +10.7% 2.50 US$25,000
2024-08-27 2024-08-23 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
10,000 +7.4%
2.50
US$25,000 		10,000 +7.4% 2.50 US$25,000
2024-08-27 2024-08-23 B Purchase
3.4
glassman steven mark
Non-Executive Director
10,000 +7.4%
2.50
US$25,000 		10,000 +7.4% 2.50 US$25,000
2024-08-27 2024-08-23 B Purchase
3.4
Drapczuk Adam E III

Chief Financial Officer

Officer
10,000 +21.1%
2.50
US$25,000 		10,000 +21.1% 2.50 US$25,000
2024-03-05 2024-03-01 B Purchase
3.4
Drapczuk Adam E III

Chief Financial Officer

Officer
47,394 +inf%
2.11
US$100,001 		47,394 +inf% 2.11 US$100,001
2024-03-05 2024-03-01 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
23,697 +21.2%
2.11
US$50,001 		23,697 +21.2% 2.11 US$50,001
2024-03-05 2024-03-01 B Purchase
3.4
glassman steven mark
Non-Executive Director
11,848 +9.6%
2.11
US$24,999 		11,848 +9.6% 2.11 US$24,999
2023-12-26 2023-12-22 B Purchase
3.4
glassman steven mark
Non-Executive Director
3,885 +3.3%
2.20
US$8,535 		3,885 +3.3% 2.20 US$8,535
2023-09-28 2023-09-26 B Purchase
3.2
Stein John Nachum
Non-Executive Director
2,500 +0.5%
1.96
US$4,900 		2,500 +0.5% 1.96 US$4,900
2023-09-14 2023-09-14 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
500 +0.4%
2.27
US$1,135 		500 +0.4% 2.27 US$1,135
2023-09-14 2023-09-13 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
6,000 +5.7%
2.25
US$13,499 		6,000 +5.7% 2.25 US$13,499
2023-09-14 2023-09-12 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
4,000 +3.9%
2.28
US$9,115 		4,000 +3.9% 2.28 US$9,115
2023-08-23 2023-08-22 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
980 +1.0%
1.92
US$1,882 		980 +1.0% 1.92 US$1,882
2023-08-23 2023-08-21 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
2,000 +2.0%
1.95
US$3,900 		2,000 +2.0% 1.95 US$3,900
2023-06-12 2023-06-08 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
3,558 +3.7%
2.24
US$7,984 		3,558 +3.7% 2.24 US$7,984
2023-06-09 2023-06-08 B Purchase
3.2
Stein John Nachum
Non-Executive Director
5,000 +1.0%
2.28
US$11,400 		5,000 +1.0% 2.28 US$11,400
2023-06-09 2023-06-08 B Purchase
2.0
STEFANSKY DAVID
Non-Executive Director
1,000 +2.0%
2.22
US$2,220 		1,000 +2.0% 2.22 US$2,220
2023-06-09 2023-06-07 B Purchase
3.2
Stein John Nachum
Non-Executive Director
5,000 +1.0%
2.69
US$13,450 		5,000 +1.0% 2.69 US$13,450
2023-06-09 2023-06-07 B Purchase
2.0
STEFANSKY DAVID
Non-Executive Director
2,000 +4.2%
2.50
US$5,000 		2,000 +4.2% 2.50 US$5,000
2023-06-02 2023-06-02 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
2,000 +2.2%
2.40
US$4,800 		2,000 +2.2% 2.40 US$4,800
2023-06-02 2023-05-31 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
1,000 +1.1%
2.25
US$2,250 		1,000 +1.1% 2.25 US$2,250
2023-06-01 2023-05-31 B Purchase
2.0
STEFANSKY DAVID
Non-Executive Director
2,000 +4.4%
2.42
US$4,840 		2,000 +4.4% 2.42 US$4,840
2023-06-01 2023-05-30 B Purchase
3.4
glassman steven mark
Non-Executive Director
4,200 +3.6%
2.38
US$9,996 		4,200 +3.6% 2.38 US$9,996
2023-06-01 2023-05-30 B Purchase
2.0
STEFANSKY DAVID
Non-Executive Director
5,000 +12.5%
2.53
US$12,650 		5,000 +12.5% 2.53 US$12,650
2023-05-30 2023-05-26 B Purchase
3.1
ZELDIS JEROME B
Non-Executive Director
5,000 +5.7%
2.34
US$11,688 		5,000 +5.7% 2.34 US$11,688
2023-05-24 2023-05-24 B Purchase
3.6
Henry Scott Robert
Non-Executive Director
2,000 +2.2%
2.01
US$4,020 		2,000 +2.2% 2.01 US$4,020
Explore more

More insider trading research around Nexgel Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America